Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses

Author： Prabakaran Ponraj Zhu Zhongyu Xiao Xiaodong Biragyn Arya Dimitrov Antony S Broder Christopher C Dimitrov Dimiter S

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.9, Iss.3, 2009-03, pp. : 355-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies

By Guillon Patrice Clment Monique Sbille Vronique Rivain Jean-Grard Chou Chih-Fong Ruvon-Clouet Nathalie Le Pendu Jacques

Glycobiology, Vol. 18, Iss. 12, 2008-12 ,pp. : 1085-1093

Oxford University Press

Access to resources Recommend Favorite

Letter to the Editor: ¹H, ¹³C, and ¹⁵N resonance assignments of the N-terminal domain of the SARS CoV nucleocapsid protein

By Zhong Nan Huang Qing Jin Changwen Xia Bin

Journal of Biomolecular NMR, Vol. 31, Iss. 1, 2005-01 ,pp. : 79-80

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal Antibodies to Human Thioredoxin Reductase

By Söderberg A. Sahaf B. Holmgren A. Rosén A.

Biochemical and Biophysical Research Communications, Vol. 249, Iss. 1, 1998-08 ,pp. : 86-89

Elsevier

Access to resources Recommend Favorite

Immunoadhesins: An Alternative to Human Monoclonal Antibodies

By Ashkenazi A. Chamow S.M.

Methods, Vol. 8, Iss. 2, 1995-10 ,pp. : 104-115

Academic Press

Access to resources Recommend Favorite

Characteristics of monoclonal antibodies against human thyroid peroxidase for use in immunoaffinity chromatography and immunoassays

By Tsyganova O. Kiseleva E. Vashkevich I. Pryadko A. Sviridov O.

Applied Biochemistry and Microbiology, Vol. 42, Iss. 1, 2006-01 ,pp. : 89-96

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite